1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics in North America Countries, September 2016 (p7)

Biopharmaceutical Analysis & Statistics in North America Countries, September 2016 (p7)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

181-210 of about 1400 reports

Purchase Reports From Reputable Market Research Publishers

Synapse Biomedical, Inc. - Medical Equipment - Deals and Alliances Profile

Synapse Biomedical, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary Synapse Biomedical, Inc. (SBI) is a medical device company that develops, manufactures and distributes neurostimulation devices for the neurology market. The company’s NeuRx Diaphragm Pacing ...

  • Industries : Medical Device
  • Countries : United States
Sanofi SA - Strategy, SWOT and Corporate Finance Report

Sanofi SA - Strategy, SWOT and Corporate Finance Report

  • $ 175
  • Company report
  • October 2016
  • by MarketLine

Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product ...

  • Industries : Therapy, Pathology
  • Countries : United States
Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis

Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis

  • $ 125
  • Company report
  • October 2016
  • by Canadean Ltd

Summary Canadean's "Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The ...

  • Industries : Biopharmaceutical
  • Countries : United States
Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis

Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis

  • $ 125
  • Company report
  • October 2016
  • by Canadean Ltd

Summary Canadean's "Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile ...

  • Countries : United States
Eurocine Vaccines AB

Eurocine Vaccines AB

  • $ 99
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Eurocine Vaccines AB compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biopharmaceutical
  • Countries : Sweden, United States, World
Epirus Biopharmaceuticals Inc

Epirus Biopharmaceuticals Inc

  • $ 99
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Epirus Biopharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Galena Biopharma Inc

Galena Biopharma Inc

  • $ 99
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Galena Biopharma Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omega Protein Corporation

Omega Protein Corporation

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Omega Protein Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biopharmaceutical
  • Countries : United States
VBI Vaccines Inc

VBI Vaccines Inc

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for VBI Vaccines Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biopharmaceutical, Therapy, Pharmaceutical, Biotechnology
  • Countries : United States, World
Navidea Biopharmaceuticals Incorporated

Navidea Biopharmaceuticals Incorporated

  • $ 87
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Navidea Biopharmaceuticals Incorporated compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Alder Biopharmaceuticals Inc

Alder Biopharmaceuticals Inc

  • $ 87
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Alder Biopharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Array BioPharma Inc.

Array BioPharma Inc.

  • $ 87
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Array BioPharma Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biopharmaceutical
  • Countries : United States
Theravance Biopharma Inc

Theravance Biopharma Inc

  • $ 87
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Theravance Biopharma Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nexvet Biopharma plc

Nexvet Biopharma plc

  • $ 87
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Nexvet Biopharma plc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biopharmaceutical
  • Countries : United States
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the co-development deals and ...

  • Industries : Pathology, Healthcare, Pharmaceutical, Therapy, Biotechnology, Cancer, Biopharmaceutical, General Medicine and Specialty Medicine
  • Countries : United States
NPS+ Rheumatoid Arthritis (EU5)

NPS+ Rheumatoid Arthritis (EU5)

  • $ 2668
  • Industry report
  • September 2016
  • by Firstword Pharma

Two leading brands continue to dominate satisfaction scores. Where does your brand rank? Few brands are earning high satisfaction scores in the European rheumatoid arthritis (RA) treatment market, but ...

  • Industries : Biopharmaceutical
  • Countries : United States
Analyzing the Global Diabetes Market 2016

Analyzing the Global Diabetes Market 2016

  • $ 1000
  • Industry report
  • September 2016
  • by Aruvian's R'search

Diabetes is a chronic disease in which there are high levels of sugar in the blood. The World Diabetes Foundation estimates that there will be 438 million people with diabetes by the year 2030. Oral anti-diabetics ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States, World
Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies ...

  • Industries : Biopharmaceutical, Biotechnology, Pharmaceutical, Pathology, Therapy, Cancer, Healthcare
  • Countries : United States
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010- 2016

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010- 2016

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010- 2016 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, ...

  • Industries : Pharmaceutical, Pathology, Therapy, Biotechnology, Healthcare, Biopharmaceutical, Cancer, General Medicine and Specialty Medicine, Chronic Disease
  • Countries : United States
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

  • $ 1995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the joint venture deals and ...

  • Industries : Pathology, Healthcare, Pharmaceutical, Biotechnology, Therapy, General Medicine and Specialty Medicine, Cancer, Biopharmaceutical
  • Countries : United States
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Cancer Monoclonal Antibody Partnering 2010-2016: Deal trends, players, financials and forecasts report provides an understanding and access to the cancer monoclonal antibody partnering deals ...

  • Industries : Biopharmaceutical, Cancer, Biotechnology, Pathology, Pharmaceutical, Therapy
  • Countries : United States
Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides details of the latest merger and acquisition (M&A) agreements announced in the pharmaceutical, ...

  • Industries : Pharmaceutical, Healthcare, Pathology, General Medicine and Specialty Medicine, Therapy, Biotechnology, Diagnostics, Biopharmaceutical
  • Countries : United States, North America, World
Traveler’s Diarrhea - Pipeline Review, H2 2016

Traveler’s Diarrhea - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Traveler’s Diarrhea - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Traveler’s Diarrhea - Pipeline Review, H2 2016’, provides an overview of the Traveler’s Diarrhea pipeline landscape. ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States
Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016’, provides ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology
  • Countries : United States
DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Genomics
  • Countries : United States, World, France
Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2016

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Poxviridae Infections - Pipeline Review, H2 2016

Poxviridae Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Poxviridae Infections - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Poxviridae Infections - Pipeline Review, H2 2016’, provides an overview of the Poxviridae Infections pipeline landscape. ...

  • Industries : Therapy, Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : United States
TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or ALK5 or TGFBR1 or EC 2.7.11.30) - Pipel

TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or ALK5 or TGFBR1 or EC 2.7.11.30) - Pipel

  • $ 3500
  • Industry report
  • August 2016
  • by Global Markets Direct

TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Recepto ...

  • Industries : Therapy, Biopharmaceutical
  • Countries : World, United States
Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology
  • Countries : United States, World
3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.